Analysis of Prescriptions on the Compatibility of Chinese Patent Medicines Containing Salvia Miltiorrhiza,Radix et Rhizoma Glycyrrhizae and Radix et Rhizoma Rhei with Western Medicines
- VernacularTitle:含丹参、甘草、大黄的中成药与西药配伍的处方分析
- Author:
Xin ZHAO
;
Yiheng YANG
- Publication Type:Journal Article
- Keywords:
Radix et Rhizoma Glycyrrhizae;
Radix et Rhizoma Rhei;
Salvia Miltiorrhiza;
Compatibility;
Analysis
- From:
China Pharmacy
2007;0(36):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To improve the rational compatible use of Chinese patent medicines with western medicines. METHODS:A total of 24 000 prescriptions were randomly sampled from July 10th to July 15th in 2006 for an analysis of the compatibility of Chinese patent medicines containing Salvia miltiorrhiza,Radix et Rhizoma Glycyrrhizae,Radix et Rhizoma Rhei with western medicines.RESULTS:Of the total 24 000 prescriptions analyzed,6 830(or 3 213 patients) involved combined use of Chinese patent medicines with western medicines,of which,the irrational combination for Salvia miltiorrhiza-contained,Radix et Rhizoma Glycyrrhizae-contained and Radix et Rhizoma Rhei-contained Chinese medicines with western medicines totalled 128,118 and 16 cases respectively.CONCLUSION:When the Chinese patent medicines being used in combination with western medicines,their physicochemical and pharmacological properties should be taken into fully consideration so as to achieve rational combination.
